The patented SKAN NANOX Catalysts enable higher efficiency breakdown of hydrogen peroxide at lower temperatures for shorter decontamination cycles.
The patented SKAN NANOX Catalysts were developed in cooperation with a Swiss university and engineered to enable higher efficiency breakdown of hydrogen peroxide at lower temperatures. The catalyst reduces the overall time and energy required for hydrogen peroxide-based decontamination and aeration, while positively impacting the effect on the environment.
The catalyst can be used in aseptic processing isolators, such as SKAN’s modular, small-scale Pharmaceutical Safety Isolator (PSI-L) with SARA material airlocks for conventional aseptic applications. The short decontamination cycle and the return air filter make it a universal, aseptic workspace for the production of aseptic and/or highly active pharmaceutical products.
Source: SKAN
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.